• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage publications.
BACKGROUND This randomized, double-blind, phase II study assessed two doses of the selective estrogen receptor modulator arzoxifene in women with advanced breast cancer. The primary end point was to(More)
PURPOSE To evaluate serum changes of matrix metalloproteinases (MMPs) 2 and 9, vascular endothelial growth factor (VEGF) and epidermal growth factor receptor (EGFR) levels in patients with advanced(More)
631 Background: Third-generation nonsteroidal aromatase inhibitors (AIs) are used as adjuvant and 1st-line metastatic therapy for postm HR+ ABC. However, many patients (pts) subsequently experience(More)